drugset / Trial / NCT05865028
A Proof of Concept Trial Investigating Safety and Efficacy of APG-157 in Oral Dysplasia
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess whether APG-157 can reduce the tumor size in participants with the study disease. Another purpose is to find out about the effects of APG-157 on certain tumor markers and oral rinses in participants with the study disease.
Timeline
- Start
- 2023-05-24
- Primary completion
- 2027-05-24
- Completion
- 2028-05-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | APG-157 | Unknown | 200 mg | Oral |